Influenza Virus A/Darwin/9/2021 San-010 (H3N2), Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), A/Victoria/4897/2022 (H1N1)Pdm09-Like Strain (A/Victoria/4897/2022, Ivr-238)

1 trials JAnti-infectives

Filter these 1 trials by condition, phase, country and more.

Open in Search →

1 Registered trials

0 Recruiting

1 Completed trials

1 Sponsors

5 Countries

Phase III

Phase III: 1

Indications tested

Influenza immunisation 1

Sponsors using this IMP

Abbott Biologicals B.V. 1

All trials

1 total

A Phase 3 Study to Assess the Safety and Immunogenicity of High-dose Influenza Vaccine in Adults ≥ 60 years of Age Ended

2024-519743-15-00 Phase III 5 countries Abbott Biologicals B.V.

Showing 1–1 of 1 trials

← All drugs A–Z